TA
YMAB

Teachers Advisors’s Y-mAbs Therapeutics YMAB Stock Holding History

Teachers Advisors’s Portfolio YMAB Stock Details YMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$248K Buy
+9,446
New +$207K ﹤0.01% 2797

Other funds holding YMAB

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Teachers Advisors's YMAB Position: Q1 2019 in Review

Teachers Advisors opened a new position in Y-mAbs Therapeutics (YMAB) in Q1 2019: 9,446 shares worth $248K. The stake represents ﹤0.01% of the portfolio and ranks #2797 among its holdings.

45 funds tracked by Wall St. Rank hold YMAB as of Q1 2019.

  • Teachers Advisors held 9,446 shares of Y-mAbs Therapeutics worth $248K as of Q1 2019.
  • Y-mAbs Therapeutics was a new Teachers Advisors position in Q1 2019.
  • Y-mAbs Therapeutics made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #2797 holding.
  • 45 funds tracked by Wall St. Rank held Y-mAbs Therapeutics as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.